Positive cardiac remodeling after cardiac myosin inhibitor therapy

29 August 2026 (08:45 - 09:00)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Chun Kit Wong

Princess Margaret Hospital, Hong Kong (Hong Kong)

3 More presentations in this session

Presentation thumbnail

Understanding the treatment of hypertrophic cardiomyopathy through clinical cases - get ready for the session

Doctor G. Bruno (Limerick, IE)

Presentation thumbnail

An atypical phenotype of hypertrophic cardiomyopathy presenting with sustained monomorphic ventricular tachycardia: involvement of the posterior left ventricular free wall

Doctor B. Akincioglu (Ankara, TR)

Presentation thumbnail

Dual-chamber leadless pacing in drug-intolerant dynamic obstructive hypertrophic cardiomyopathy with absent right superior vena cava and persistent left superior vena cava

Doctor K. Kurogi (Miyazaki, JP)

Access the full session

Session thumbnail

Understanding the treatment of hypertrophic cardiomyopathy through clinical cases

The Event

Event poster

ESC Congress 2026

29 August 2026 08:45 CET

You may be interested in

Congress Presentation

Cardiac myosin inhibitors use in the real world: what you need to know

30 August 2025

Congress Presentation

Relationship of myocardial fibrosis markers with cardiac structural and functional parameters in patients with post-myocardial infarction.

29 June 2021

Webinar

2022 ESC Guidelines on Cardio-Oncology: how to implement cancer treatment monitoring in daily practice

23 February 2023

Congress Presentation

Cardiac myosin inhibitor, mavacamten, improves myocardial relaxation in mouse HFpEF model

30 April 2022

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources